Route of administration of phosphate replacement in the IC

Phase 4

Completed

• Conditions: hypophosphatemia; critical illness; Metabolic and Endocrine - Other metabolic disorders; Diet and Nutrition - Other diet and nutrition disorders

• Registration Number: ACTRN12622000533796
• Lead Sponsor: Royal Melbourne Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-04-05
• Study Completion: 2023-06-01
• Last Update Posted: 9 September 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 145

Inclusion Criteria

All adult patients admitted to RMH ICU who require phosphate replacement with serum phosphate level <0.75mmol/l.

Exclusion Criteria

- Serum phosphate concentration <0.3mmol/L, i.e., severe hypophosphatemia
- Either enteral or parenteral replacement is not possible (i.e., no enteric feeding tube, intolerance of enteral feeding with gastric aspiration >300ml or no intravenous line)
- Treating clinician believes that either enteral or parenteral phosphate replacement is indicated for this patient

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome measure is serum phosphate level measured before phosphate replacement and 24 hours after replacement.[ Prior to phosphate replacement and 24 hours after replacement.]